bioMérieux has acquired Accellix for about €35 million, adding rapid, automated flow cytometry to its pharmaceutical quality control portfolio for cell and gene therapy manufacturing.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
The BLOODPAC Consortium has released new analytical validation standards for liquid biopsy MRD tests, offering industry-wide protocols for tumor-informed ctDNA assay development, as detailed in JCO Precision Oncology.
Data Innovations has launched Instrument Manager v9.01, introducing enhanced security features to address evolving cybersecurity demands and improve lab workflow, according to the company.
BillionToOne has partnered with Epic to integrate its UNITY Complete prenatal and Northstar oncology tests into Epic’s EHR system, enabling direct ordering and results delivery for healthcare providers.
